美團(3690.HK)大漲8%再創歷史新高 市值超越工行位居港股第三
格隆匯1月20日丨美團(3690.HK)午後漲幅進一步擴大,一度漲8.09%至368.6港元,再創歷史新高,市值超2.16萬億港元,超越工商銀行位居港股第三位,僅次於騰訊和阿里巴巴。該股月內已累漲近25%。美團入選了格隆匯2021年“下注中國”十大核心資產名單。據統計,截至1月19日,南下資金連續10個交易日淨買入美團,共計71.39億港元。小摩最新指出,估計美團用户增長加快,及團購業務的城市覆蓋和成交總額(GMV)提升將成為近期股價的催化劑,將美團目標價由270港元上調至450港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.